SignalCorporate
Tangential Flow Filtration - Global Strategic Business Report 2026: Capitalize on a $2B Revenue Shift to $3.6B by 2032 as Danaher, MilliporeSigma, GE Healthcare, and Alfa Laval Accelerate Competition
$2B to $3.6B by 2032 revenue growth forecast with Danaher, MilliporeSigma, GE Healthcare, and Alfa Laval competition.
Context
What happened: ResearchAndMarkets.com added the "Tangential Flow Filtration - Global Strategic Business Report 2026," covering market trends, segmentation, regional outlook, and competitive positioning.
Key numbers: Market valued at US$1.6 billion in 2025, projected to reach US$3.6 billion by 2032 at an 11.9% CAGR.
Why it matters: The report attributes growth to rising biopharmaceutical production, biologics and vaccine demand, membrane technology advances, and adoption of continuous bioprocessing, and profiles competitors including Danaher, MilliporeSigma, GE Healthcare, and Alfa Laval.
Coverage: 4 outlets in 24h
What changed
ResearchAndMarkets.com added the "Tangential Flow Filtration - Global Strategic Business Report 2026," covering market trends, segmentation, regional outlook, and competitive positioning.
Why it matters
The report attributes growth to rising biopharmaceutical production, biologics and vaccine demand, membrane technology advances, and adoption of continuous bioprocessing, and profiles competitors including Danaher, MilliporeSigma, GE Healthcare, and Alfa Laval.